![]() |
Predicting Risk For Recurrence For Patients With DCIS Breast Cancer
In a significant advance for patients with ductal carcinoma in situ, researchers have developed and prospectively validated a multigene test to identify the risk for recurrence of breast cancer...
More... |
| All times are GMT -7. The time now is 08:09 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021